396 results on '"Miyakita, Yasuji"'
Search Results
102. Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation
103. A Case of Metastatic Intracranial Malignant Melanoma Mimicking Simple Subcortical Hemorrhage in an Elderly Woman
104. Three Cases of Sub-scalp Tumor Presenting with Protrusion of the Head
105. A rare case of brain metastasis from poorly differentiated small bowel adenocarcinoma
106. Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse Glioma
107. NQPC-10 END-OF-LIFE PHASE OF GLIOBLASTOMA
108. MPC-11 IDH1/2 MUTATIONS ARE ASSOCIATED WITH SEIZURE ONSET AND VETRY IMAGING IN PATIENTS WITH DIFFUSE GLIOMA VISUALIZING 2-HYDROXYGLUTARATE BY MASS SPECTRUM
109. COT-15 LITERATURE REVIEW ON THE DECISION MAKING OF THE BRAIN TUMOR PATIENT
110. NQPC-14 COMPARISON OF QOL SCALES IN PATIENTS WITH BRAIN TUMORS
111. COT-04 FAMILY SUPPORT FOR PATIENTS WITH PRIMARY MALIGNANT BRAIN TUMORS BY PATIENT SUPPORT GROUP IN NATIONAL CANCER CENTER
112. NQPC-13 THE EFFICACY OF RAVEN’S COLORED PROGRESSIVE MATRICES FOR PATIENTS WITH BRAIN TUMOR
113. COT-23 INITIAL EXPERIENCE OF TREATMENT FOR GLIOBLASTOMA BY NOVO-TTF
114. ACT-14 A FIRST-IN-HUMAN STUDY OF MUTANT IDH1 INHIBITOR DS-1001B IN PATIENTS WITH RECURRENT GLIOMAS
115. ACTR-17. DIAGNOSTIC UTILITY OF SERUM microRNA CLASSIFICATION IN DIFFUSE GLIOMA
116. QOLP-40. END-OF-LIFE CARE FOR GLIOBLASTOMA PATIENTS IN JAPAN
117. Phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001b in patients with recurrent or progressive IDH1 mutant gliomas.
118. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment**.
119. Diagnostic Ability of Serum microRNA Classification in Diffuse Glioma: A Retrospective Comprehensive Analysis with Case-Control Study
120. Longitudinal Follow-up of a Case of Multinodular and Vacuolating Neuronal Tumor of the Cerebrum and Review of the Literature
121. Frequent false-negative immunohistochemical staining with IDH1 (R132H)-specific H09 antibody on frozen section control slides: a potential pitfall in glioma diagnosis
122. NCMP-09. ISOCITRATE DEHYDROGENASE MUTATIONS AND INCREASED TISSUE 2-HYDROXYGLUTARATE CONCENTRATION MIGHT BE RELATED WITH SEIZURE ONSET IN PATIENTS WITH GLIOMAS
123. INTRAVASCULAR LYMPHOMA OF THE CENTRAL NERVOUS SYSTEM PRESENTING AS MULTIPLE CEREBRAL INFARCTIONS
124. Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2Ahomozygous deletion in the assessment of adult-type infiltrating astrocytoma
125. Impact of Surgical Margin in Skull Base Surgery for Head and Neck Sarcomas
126. Additional file 3: Figure S1. of A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
127. ACTR-07. LIMITED IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE BEYOND 12 CYCLES IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAS
128. Outcomes of Surgery followed by Local Brain Radiotherapy Compared with Surgery followed by Whole Brain Radiotherapy for Single Brain Metastasis
129. MPTH-22. SERUM 2-HYDROXYGLUTARATE (2HG) LEVELS ARE CORRELATED WITH TISSUE 2HG LEVELS IN ISOCITRATE DEHYDROGENASE 1 AND 2 GENES (IDH1/2)-MUTATED GLIOMAS BUT NOT IN IDH1/2-WILDTYPE GLIOMAS
130. A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas
131. Health-related quality of life in outpatients with primary central nervous system lymphoma after radiotherapy and high-dose methotrexate chemotherapy
132. Frequent false‐negative immunohistochemical staining with IDH1 (R132H)‐specific H09 antibody on frozen section control slides: a potential pitfall in glioma diagnosis.
133. Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial.
134. Glioblastomas withIDH1/2mutations have a short clinical history and have a favorable clinical outcome
135. EPIG-18PYROSEQUENCING ANALYSIS OF THE MGMT PROMOTER METHYLATION STATUS IN NEWLY DIAGNOSED GLIOBLASTOMA CORRELATES WITH VOLUMETRIC CHANGES OF UNRESECTED ENHANCED LESIONS IN MRI AFTER STANDARD RADIATION AND TEMOZOLOMIDE THERAPY
136. Fourteen cases of ADL and cognitive function during high-dose methotrexate treatment for malignant primary CNS lymphoma
137. The necessity of long-term follow-up including spinal examination after successful initial treatment of intracranial germinoma: case reports
138. Molecular imaging using PET for breast cancer
139. Comparison of Genetic Profiling of Primary Central Nervous System (CNS) Lymphoma before and after Extra-CNS Relapse
140. Olfactory Preservation in Craniofacial Resection of Tumor Invading Hemianterior Skull Base: Operative Video.
141. Spinal Dissemination of Intracranial Germinoma 7 and 9 Years after Complete Remission of Initial Treatment—2 Cases Reports—
142. RevisitingTP53Mutations and Immunohistochemistry-A Comparative Study in 157 Diffuse Gliomas
143. Development of a robust and sensitive pyrosequencing assay for the detection of IDH1/2 mutations in gliomas
144. Risk factors for early death after surgery in patients with brain metastases: reevaluation of the indications for and role of surgery
145. Short communication: sclerosing meningioma in the deep sylvian fissure
146. Clinical presentation of anaplastic large-cell lymphoma in the central nervous system
147. The necessity of long-term follow-up including spinal examination after successful initial treatment of intracranial germinoma: case reports.
148. Randomized trial of chemoradiotherapy and adjuvant chemotherapy with nimustine (ACNU) versus nimustine plus procarbazine for newly diagnosed anaplastic astrocytoma and glioblastoma (JCOG0305)
149. Management of glioblastoma in an NF1 patient with moyamoya syndrome: a case report
150. IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.